Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Apoptosis

• Publication date

  2015-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10495-015-1103-7PMID 25673107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gangliosides drive the tumor infiltration and function of myeloid-derived suppressor cells.

  2014cited by this paper
• Ganglioside GD2 in reception and transduction of cell death signal in tumor cells

  2014cited by this paper
• Endothelin A Receptor Antagonism Enhances Inhibitory Effects of Anti-Ganglioside GD2 Monoclonal Antibody on Invasiveness and Viability of Human Osteosarcoma Cells

  2014cited by this paper
• Early stage fetal neocortex exhibits a complex ganglioside profile as revealed by high resolution tandem mass spectrometry

  2014cited by this paper
• Evidence for the involvement of GD3 ganglioside in autophagosome formation and maturation

  2014cited by this paper
• Tumor gangliosides accelerate murine tumor angiogenesis

  2014cited by this paper
• Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy

  2014cited by this paper
• Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis

  2013cited by this paper
• Deacetylated GM3 Promotes uPAR-Associated Membrane Molecular Complex to Activate p38 MAPK in Metastatic Melanoma

  2013cited by this paper
• Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo.

  2013cited by this paper
• The role of gangliosides in brain development and the potential benefits of perinatal supplementation.

  2013cited by this paper
• Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells.

  2013cited by this paper
• Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches

  2013cited by this paper
• NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin

  2012cited by this paper
• Application of Molecular Mimicry to Target GD2 Ganglioside

  2012cited by this paper
• The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.

  2012cited by this paper
• Ganglioside Inhibition of CD8+ T Cell Cytotoxicity: Interference with Lytic Granule Trafficking and Exocytosis

  2012cited by this paper
• The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

  2012cited by this paper
• Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry

  2012cited by this paper
• Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3

  2012cited by this paper
• Bioactive Sphingolipids in Neuroblastoma

  2012cited by this paper
• Regulatory Mechanisms of Nervous Systems with Glycosphingolipids

  2011cited by this paper
• Chip-based nanoelectrospray mass spectrometry of brain gangliosides.

  2011cited by this paper
• Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

  2011cited by this paper
• Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism

  2011cited by this paper
• Structures, biosynthesis, and functions of gangliosides--an overview.

  2011cited by this paper
• Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside‐deficient mutant mice

  2011cited by this paper
• A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity

  2011cited by this paper
• GD3 Synthase Expression Enhances Proliferation and Tumor Growth of MDA-MB-231 Breast Cancer Cells through c-Met Activation

  2010cited by this paper
• Revitalizing membrane rafts: new tools and insights

  2010cited by this paper
• Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

  2010cited by this paper
• Gangliosides in cell recognition and membrane protein regulation.

  2009cited by this paper
• Raft component GD3 associates with tubulin following CD95/Fas ligation

  2009cited by this paper
• Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.

  2009cited by this paper
• Glycosphingolipid behaviour in complex membranes.

  2009cited by this paper
• The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.

  2009cited by this paper
• The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

  2009cited by this paper
• Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity

  2008cited by this paper
• Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

  2008cited by this paper
• Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.

  2008cited by this paper
• Ganglioside GM2-Tetraspanin CD82 Complex Inhibits Met and Its Cross-talk with Integrins, Providing a Basis for Control of Cell Motility through Glycosynapse*

  2007cited by this paper
• GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells

  2007cited by this paper
• A novel HSF1‐mediated death pathway that is suppressed by heat shock proteins

  2006cited by this paper
• Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.

  2005cited by this paper
• Low complex ganglioside expression characterizes human neuroblastoma cell lines.

  2005cited by this paper
• Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy

  2005cited by this paper
• Mechanisms for the Apoptosis of Small Cell Lung Cancer Cells Induced by Anti-GD2 Monoclonal Antibodies

  2005cited by this paper
• Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid

  2004cited by this paper
• Ganglioside/glycosphingolipid turnover: New concepts

  2003cited by this paper
• Role of tumor-associated gangliosides in cancer progression.

  2003cited by this paper
• Peripheral neuropathies and anti-glycolipid antibodies.

  2002cited by this paper
• An Anti‐GD2 Monoclonal Antibody Enhances Apoptotic Effects of Anti‐cancer Drugs against Small Cell Lung Cancer Cells via JNK (c‐Jun Terminal Kinase) Activation

  2002cited by this paper
• Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.

  2001cited by this paper
• Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro

  2000cited by this paper
• Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.

  1999cited by this paper
• Gangliosides expressed in human breast cancer.

  1996cited by this paper
• Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients

  1995cited by this paper
• Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line.

  1991cited by this paper
• Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas

  1991cited by this paper
• Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

  1985cited by this paper
• Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody.

  1984cited by this paper
• GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

  1982cited by this paper

• Xiaojianzhong decoction inhibits gastric cancer progression and enhances 5-Fu efficacy by regulating the MAPK and PI3K-AKT signaling pathway.

  2025cites this paper
• Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis

  2024cites this paper
• Apoptosis is responsible for the cytotoxic effects of anti-GD2 ganglioside antibodies and aurora A kinase inhibitors on human neuroblastoma cells.

  2022cites this paper
• SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7

  2022cites this paper
• The Extracellular Matrix and Neuroblastoma Cell Communication—A Complex Interplay and Its Therapeutic Implications

  2022cites this paper
• RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype

  2020cites this paper
• Gangliosides and Tumor-Associated Ganglioside (TAG) Modulate Receptor-Tyrosine Kinases (RTKs)

  2020cites this paper
• Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma

  2020cites this paper
• Influence of glycosphingolipids on cancer cell energy metabolism.

  2020cites this paper
• MALDI-2 Mass Spectrometry and Immunohistochemistry Imaging of Gb3Cer, Gb4Cer, and Further Glycosphingolipids in Human Colorectal Cancer Tissue.

  2020cites this paper
• Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations.

  2019cites this paper
• Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies

  2019cites this paper
• Identification and characterization of a T-2 toxin-producing Fusarium poae strain and the anti-tumor effect of the T-2 toxin on human hepatoma cell line SMMC-7721

  2019cites this paper
• UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway

  2019cites this paper
• A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells

  2019cites this paper
• Increased CDKL3 expression predicts poor prognosis and enhances malignant phenotypes in esophageal squamous cell carcinoma

  2018cites this paper
• Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice

  2018cites this paper
• Gangliosides in Cancer Cell Signaling.

  2018cites this paper
• Sialic acid as a target for the development of novel antiangiogenic strategies.

  2018cites this paper
• One-step synthesis of gene carrier via gamma irradiation and its application in tumor gene therapy

  2018cites this paper
• Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection

  2018cites this paper
• Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.

  2017cites this paper
• [Quinalizarin induces apoptosis in gastric cancer AGS cells via MAPK and Akt signaling pathway].

  2017cites this paper
• Proteomics for Drug Discovery

  2017cites this paper
• Microfluidics-Mass Spectrometry of Protein-Carbohydrate Interactions: Applications to the Development of Therapeutics and Biomarker Discovery.

  2017cites this paper
• In vivo and in vitro induction of the apoptotic effects of oxysophoridine on colorectal cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway

  2017influential citation
• At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody

  2016cites this paper
• Metabotropic glutamate receptor 3 is involved in B-cell-related tumor apoptosis.

  2016influential citation
• Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents

  2016cites this paper
• Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice

  2016cites this paper
• Ganglioside as a Therapy Target in Various Types of Cancer.

  2016cites this paper
• Analysis of genes involved in response to doxorubicin and a GD2 ganglioside-specific 14G2a monoclonal antibody in IMR-32 human neuroblastoma cells.

  2015cites this paper
• The role of sphingolipids and lipid rafts in determining cell fate

  2015cites this paper